Clinical Outcome of Pediatric Dermatofibrosarcoma Protuberans

Soft Tissue Neoplasms Clinical Trial

Official title:

Retrospective Clinical Outcome Study of Pediatric Dermatofibrosarcoma Protuberans: Single Institutional Experience of Twelve Cases From 1977-2002

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT00173355
• Other study ID #: 9461700618
• Status: Recruiting
• Phase: N/A
• First received: September 12, 2005
• Last updated: November 23, 2005
• Start date: June 2005
• Est. completion date: August 2005

Study information

• Verified date: August 2005
• Source: National Taiwan University Hospital
• Contact: Chun-Ru Chien, M.D.
• Phone: 886-2-23123456
• Email: stwo[@]ha.mc.ntu.edu.tw
• Is FDA regulated: No
• Health authority: Taiwan: Department of Health
• Study type: Observational

Clinical Trial Summary

Retrospective review of clinical outcome of pediatric Dermatofibrosarcoma Protuberans (PDFSP) after active invitation

Description:

Soft tissue sarcoma was rarely seen in pediatric patients, and pediatric Dermatofibrosarcoma Protuberans (PDFSP) was even rare. To our knowledge, the largest report constituted of 19 cases (five of them had no follow-up (FU) status) (1). So we proposed this retrospective study based on the cancer registry of our hospital. Twelve cases who were diagnosed as DFSP before age of 18 were identified. But all of them had been lost of FU for at least two years. So we will try to contact these patients and asked them to be back to our clinic for routine surveillance (history taking and physical exam and optional local image/chest xray) and quality of life (QoL) evaluation after pathological review if this clinical study was approved (2)

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 12
• Est. completion date: August 2005
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A to 18 Years

Eligibility

Inclusion Criteria:

• Patients diagnosed as DFSP before age of 18 after pathological review according to the cancer registry of our hospital

Exclusion Criteria:

• age > 18 at diagnosis

Study Design

Observational Model: Defined Population, Time Perspective: Longitudinal

Related Conditions & MeSH terms

• Dermatofibrosarcoma
• Soft Tissue Neoplasms

Locations

Country	Name	City	State
Taiwan	National Taiwan University Hospital	Taipei

Sponsors (1)

Lead Sponsor	Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan,